Call 1-888-805-4555 for 24/7 on-call assistance

Green patient identification card icon

Access & Reimbursement Support

Important information and resources to help navigate the reimbursement process

Bristol Myers Squibb is committed to delivering optimal patient and customer experience with cellular therapies. This information will help prescribed patients get access to our CAR T cell therapies and help treatment centers navigate the reimbursement process.

Yellow clipboard icon

Patient Access & Insurance Coverage

Verify benefits, obtain prior authorization, and finalize single case agreement (if required)

Green patient identification card icon

Claim Submission

Find information you may need to submit your claim

Phone icon

Authorized Distributor Order

Place product order for purchase via authorized distributor

Clipboard and stethoscope icon

Resource Library

Get resources such as checklists, templated letters, and flashcards

This information is provided for educational purposes only. Bristol Myers Squibb cannot guarantee insurance coverage or reimbursement. Coverage and reimbursement may vary significantly by payer, plan, patient, and setting of care, and is subject to frequent change. It is the sole responsibility of the healthcare provider to select the proper codes and ensure the accuracy of all statements used in seeking coverage and reimbursement for an individual patient.

CAR=chimeric antigen receptor.

Product-specific information and codes

For the treatment of:

  • R/R large B-cell lymphoma (R/R LBCL)
  • R/R follicular lymphoma (R/R FL)

For the treatment of:

  • R/R multiple myeloma (R/R MM)

R/R=relapsed or refractory.



Bristol Myers Squibb logo

Legal Notice           Privacy Policy          Your Privacy Choices          Site Map

This site is intended for U.S. audiences only. 

© 2024 Bristol-Myers Squibb Company. All rights reserved.
CELL THERAPY 360 and the related logo are trademarks of Celgene Corporation, a Bristol Myers Squibb company. All other trademarks are the property of their respective owners.

HE-US-2300770 04/24